letter · 2002
On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance
Gasparini and Eisele (2000, Biometrics 56, 609-615) propose a design for phase I clinical trials during which dose allocation is governed by a Bayesian nonpa...
37 citationsDOI: https://doi.org/10.1111/j.0006-341x.2002.00237.xOpen accessPDF reported by metadata